Abstract:The development of CRISPR-based gene-editing technologies has brought an unprecedented revolution in the field of genome engineering. Cas12a, a member of the Class 2 Type V CRISPR-associated endonuclease family distinct from Cas9, has been repurposed and developed into versatile gene-editing tools with distinct PAM recognition sites and multiplexed gene targeting capability. However, with current CRISPR/Cas12a technologies, it remains a challenge to perform efficient and precise genome editing of long sequences in mammalian cells. To address this limitation, we utilized phage recombination enzymes and developed an efficient CRISPR/Cas12a tool for multiplexed precision editing in mammalian cells. Through protein engineering, we were able to recruit phage recombination proteins to Cas12a to enhance its homology-directed repair efficiencies. Our phage-recombination-assisted Cas12a system achieved up to 3-fold improvements for kilobase-scale knock-ins in human cells without compromising the specificity of the enzyme. The performance of this system compares favorably against Cas9 references, the commonly used enzyme for gene-editing tasks, with improved specificity. Additionally, we demonstrated multi-target editing with similar improved activities thanks to the RNA-processing activity of the Cas12a system. This compact, multi-target editing tool has the potential to assist in understanding multi-gene interactions. In particular, it paves the way for a gene therapy method for human diseases that complements existing tools and is suitable for polygenic disorders and diseases requiring long-sequence corrections.

Strategic targeting of Cas9 nickase expands tandem gene arrays

Expanding The Crispr Imaging Toolset With Staphylococcus Aureus Cas9 For Simultaneous Imaging Of Multiple Genomic Loci

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Recombinase‐mediated Method for Multi‐scale Genomic Rearrangements

Shortened CRISPR-Cas9 arrays enable multiplexed gene targeting in bacteria from a smaller DNA footprint

Engineered Transcription Factor Binding Arrays for DNA-based Gene Expression Control in Mammalian Cells

Long sequence insertion via CRISPR/Cas gene-editing with transposase, recombinase, and integrase

Expanding the editable genome and CRISPR–Cas9 versatility using DNA cutting-free gene targeting based on in trans paired nicking

Higher-order combinatorial chromatin perturbations by engineered CRISPR-Cas12a for functional genomics

Expanding the Potential of Mammalian Genome Engineering via Targeted DNA Integration

Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity

Two Compact Cas9 Ortholog-Based Cytosine Base Editors Expand the DNA Targeting Scope and Applications In Vitro and In Vivo

A Highly Efficient Site-Specific Integration Strategy Using Combination of Homologous Recombination and the ΦC31 Integrase.

Cas9 variants expand the targeting scope of base editing systems in bacteria

Cooperativity between Cas9 and hyperactive AID establishes broad and diversifying mutational footprints in base editors

Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system

Precise and Predictable CRISPR Chromosomal Rearrangements Reveal Principles of Cas9-Mediated Nucleotide Insertion

Cas9-Assisted Targeting of Chromosome Segments Catch Enables One-Step Targeted Cloning of Large Gene Clusters

Enhanced Cas12a multi-gene regulation using a CRISPR array separator

Split Cas9, Not Hairs - Advancing the Therapeutic Index of CRISPR Technology

Site-specific DNA insertion into the human genome with engineered recombinases